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ABSTRACT Epidermolysis builosa simplex (EBS) is a
group of autosomal dominant skin diseases characterized by
blistering, due to mechanical-stress-induced degeneration of
basal epidermal cells. Recently, it was discovered that the more
severe types, Dowling-Meara and Koebner, are genetic disor-
ders of the basal epidermal keratins, keratin 5 (K5) and keratin
14 (K14). Here, we show that the mildest type of EBS,
Weber-Cockayne, is also a disorder of these keratins. Affected
members oftwo unrelated families with Weber-Cockayne EBS
had a T -* G point mutation in the second base position of
codon 161 of one of two K5 alleles, leading to an Be -+ Ser
mutation. This mutation was not present in unaffected mem-
bers or in 156 alleles from normal individuals. Linkage anal-
yses mapped the defect to the type II keratin gene cluster on
chromosome 12q11-q13 (peak logarithm of odds score at 0 =
0 of 3.0), providing strong additional evidence that this muta-
tion is responsible for the Weber-Cockayne EBS phenotype.
Conserved among type II keratins, Ile-161 is in the nonhelical
head domain of K5, a region previously shown to be important
for 10-nm filament assembly. The mutation generates a po-
tential substrate site for protein kinase C, which could influence
intermediate rfament architecture, perhaps leading to the
intrafilament association seen ultrastructurally in patients with
the mutation.
Epidermolysis bullosa simplex (EBS) has been subdivided
into three major types (1, 2). Dowling-Meara (D-M) EBS is
the most severe type, typified by blistering over whole body
regions, keratin-flament clumping, and cytolysis in basal
cells. Koebner EBS (K-EBS) is also characterized by gen-
eralized blistering and basal-cell cytolysis but with fewer
abnormalities in basal-cell keratin networks. Weber-
Cockayne (W-C) EBS is the mildest form, with blistering
concentrated primarily in palmar and plantar regions, and
very minor keratin-filament perturbations.
Anton-Lamprecht (1) originally suggested that D-M EBS
might be a disorder of keratin, based on ultrastructural
analysis of EBS skin. She noted that tonofilament clumping
often preceded cell cytolysis, making it unlikely that cytolysis
could be initiated by aberrant protease action. Experimental
support for this hypothesis was not provided until years later,
when it was discovered that transgenic mice expressing a
keratin 14 (K14) mutant displayed abnormalities bearing a
striking resemblance to D-M EBS (3). Subsequent analyses
of the two known basal-specific keratin genes of human
patients with D-M EBS or K-EBS led to the discovery of
point mutations in either the K5 or K14 genes (refs. 4-6; see
also ref. 7).
The known K14 and K5 point mutations of D-M and
K-EBS reside in the a-helical rod domains involved in
coiled-coil heterodimerization (8). D-M EBS mutations are
clustered within the highly conserved rod ends (4, 6),
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whereas the K-EBS mutation is more internal (5). When
engineered in wild-type K14 or K5 cDNA expression vectors,
the D-M EBS mutations (i) perturbed keratin network for-
mation in transfected keratinocytes and (ii) perturbed 10-nm
intermediate filament (IF) assembly in vitro (4, 9). These
aberrations were similar to those in cultured EBS kerati-
nocytes (4, 10) and in EBS IFs (4), demonstrating that the
mutations were functionally responsible for the disease. In
contrast, the K-EBS mutation exhibited milder effects on IF
assembly and network formation (9, 11), revealing a corre-
lation between the mutation and disease severity.
The genetic basis for the milder type of EBS, W-C EBS,
has not yet been determined. However, restriction fragment
length polymorphism analyses have linked W-C EBS to
either of the two major clusters of keratin genes on chromo-
somes 12 and 17 (5, 12). In addition, transgenic mice express-
ing a mildly disrupting K14 mutant exhibit basal-cell cytolysis
in their paw skin (13). Thus it seems likely that the underlying
genetic basis of W-C EBS is a mildly disrupting K14 or K5
mutation. We have now examined this possibility, using
ultrastructural, chromosomal, and sequence analyses on nine
families with W-C EBS.
MATERIALS AND METHODS
Biopsies and Blood Samples. One clinically affected mem-
ber of each family donated skin biopsies for culturing kera-
tinocytes and for ultrastructural studies (4). Blood samples
(15-20 ml) were taken for isolation of genomic DNA.
Chromosome Mapping and DNA Sequence Analysis. Nu-
cleotide primers were selected for polymerase chain reaction
(PCR) amplification of DNAs encompassing polymorphic
sites at or near the keratin clusters ofchromosomes 17 and 12.
DNAs were then resolved by gel electrophoresis, as de-
scribed (14). Primers were as follows: D17S800 (AMF200zf4),
GGTCTCATCCATCAGGTTTT and ATAGACTGTGTAC-
TGGGCATTGA (14); D17S846 (GAS), TGCATACCTG-
TACTACTTCAG and TCCTTTGTTGCAGATTTCTTC
(15); Kl, ATAACTGAGCTTCCTCTTGC and GGATC-
CCCGGCCTCCTATGG. RNAs from cultured keratinocytes
were primed with random hexamers and reverse-transcribed
into cDNA (4). Reaction products were amplified by PCR and
sequenced, using biotinylated primers and solid-phase DNA
sequencing or CircumVent (New England Biolabs). K5 prim-
ers were chosen from the published sequence (16, 17).
RESULTS
Diagnosis of EBS Families. Affected family members ex-
hibited mild blistering of palmar and plantar skin upon
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physical trauma. Ultrastructural analyses revealed features
typical of EBS (Fig. 1A). Approximately 30-40% of basal
epidermal cells displayed mild perturbations, including (i)
signs of vacuolization, often adjacent to the nucleus, (ii)
lateral aggregates of tonofilaments, and (iii) a sparcity of
tonofilaments. Basal keratin was filamentous and often in
wavy bundles (Fig. 1 D and E): None of the W-C EBS
samples showed signs of basal tonofilament clumping typical
ofD-M EBS. Basal nuclei often appeared irregular and in two
or more segments, suggestive of distortion or multinucleation
(Fig. 1C). Endoplasmic reticulum vesiculation and cell de-
generation were sometimes evident. None of the basal-cell
aberrancies were typical of normal skin (Fig. 1 B and F). The
mild aggregation and waviness of basal-cell keratin filaments
and the apparent distortions in basal nuclei seemed more
prominent than previously noted and provided a stronger link
between keratin-filament abnormalities and the W-C EBS
phenotype than had been appreciated.
Linkage Analyses of W-C EBS Families 37 and 26. Prior
studies on a large W-C EBS family indicated linkage [peak
logarithm of odds (lod) score at a of 0.001 = 7.43] to the
keratin cluster on chromosome 12q11-q13 (5). Similar studies
suggested linkage ofone W-C EBS family to 17ql2-q21 (peak
lod score at a of 0.1 = 2.45) and linkage of another to
12q11-q13 (peak lod score at of 0.08 = 1.37) (12).
To explore the possibility that W-C EBS may be a genetic
disorder of K14 and K5, we first tested for linkage of our
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FIG. 1. Ultrastructure ofW-C EBS. (A) Basal and spinous layers
of epidermis from affected member ofEBS family 37. Note vacuoles
and wavy tonofilament aggregates in basal cells. (B) Normal skin.
Note typically thin keratin tonofilaments in basal cells. (C) Extreme
example of nuclear abnormalities in a basal cell from affected
member of family 31. (D) High magnification of a tonofilament
aggregate and vacuoles in basal cell of skin from individual 37.7. (E)
High magnification of family-31 basal cell, showing bundles of wavy
filaments. (F) High magnification of normal basal tonofilaments. N,
nucleus; BL, basal layer; SP, spinous layer; DE, dermis; arrow-
heads, basement membrane; arrows, keratin filament bundles; as-
terisks, vacuoles. (Bars: A, 3 unm; B, 3 ,um; C, 1.7 ,um; D, 0.28 ,um;
E, 1.1 ,um; F, 0.22 gm.)
families to probes recognizing highly polymorphic loci near the
K14 gene (17ql2-q21; ref. 18). AFM200zf4 at the D17S800
locus adjacent to the keratin cluster on chromosome 17 has six
allelic variations (14). Electrophoretic separation of genomic
PCR fragments encompassing this polymorphic site revealed
that no single D17S800 allele cosegregated with the EBS
disease in family 37, and moreover, both individuals 37.3
(unaffected) and 37.7 (affected) received allele A from their
affected mother 37.2. Similarly, member 26.4 (unaffected)
inherited allele B from individual 26.1 (affected), who received
it from individual 26.5 (affected). With the AFM200zf4
marker, the lod score at 9 = 0 for family 37 was -7.23
(two-point linkage analyses were performed using the MLINK
program; the frequency of the W-C EBS allele was estimated
at 1/50,000 with a penetrance value of 1.0). Studies with
D17S849, adjacent to the keratin cluster on chromosome 17,
were consistent with the notion that the genetic defect for
these two families does not reside on chromosome 17 (Fig. 2).
To determine whether W-C EBS in families 37 and 26
might be linked to 12q11-q13, where the K5 gene resides (19),
we used two polymorphic markers. 1G12A/CA has five
allelic variations and was discovered in a cosmid that maps
to 12q12 and contains a keratin-like sequence (R. Kucherla-
pati, personal communication). While this marker was not
informative for family 26, allele B cosegregated with the
disease in family 37 (Fig. 2). The other marker detects two
allelic variations in Kl (20). Allele A, corresponding to the
larger Kl, cosegregated with the disease in both families.
These data were suggestive that the defect in these families
might be in the K5 gene.
A Point Mutation Encoding an He-- Ser Substitution Near the
Beginning of the K5 Rod Domain in W-C EBS Family 37. To
ascertain whether the K5 gene was the source of the genetic
defect in W-C EBS family 37, we isolated RNAs from kera-
tinocytes cultured from a skin biopsy from a member offamily
37 and PCR-amplified and sequenced the K5 cDNAs. Only a
single-point substitution at nt 482 (A ofthe firstATG = 1; refs.
16 and 17) distinguished one of the K5 alleles from wild type.
The transversion caused an Ile (ATC) -+ Ser (AGC) mutation
at codon 161 (Fig. 3A). The PCR and sequencing were repro-
ducible, indicating that the transversion was not due to a
polymerase error during PCR. Both adenosine and cytidine
occurred in the sequencing ladder of the noncoding strand
(thymidine and guanosine in the coding strand). When sub-
cloned, some cDNAs contained only the mutant guanosine
(Fig. 3B), while others contained the wild-type thymidine (Fig.
3C), analogous to the control (Fig. 3D). This confirmed the
presence ofboth mutant and wild-type sequences in the cDNA
pool, as expected of an autosomal dominant disease.
Cosegregation ofthe Ile-161 -- Ser Mutation with the Disease
in Two Families in W-C EBS. The Ile-161 -* Ser mutation
obliterated a Fok I site, enabling a rapid assessment of
whether the mutation cosegregated with the EBS disease
(Fig. 4). When digested with Fok I, a control 555-bp genomic
PCR DNA encompassing this site was cleaved to 406 tp. In
contrast, PCR DNAs from seven affected members of family
37 were =50% (on a molar basis) undigested. These members
were also heterozygous for an SfaNI site, also obliterated by
the T -+ G mutation (data not shown). Unaffected family
members had alleles that were homozygous for the Fok I site.
Surprisingly, affected members from W-C EBS family 26
had DNAs that were also heterozygous for the Fok I site. The
other seven families were homozygous as were 16 distinct
incidences ofD-M EBS and K-EBS. Genomic DNAs from 78
normal individuals were also homozygous verifying that the
loss of this site was not merely reflective of a rare polymor-
phic variation. When the Fok I site was used as a genetic
marker, a combined lod score at 6= 0 of 3.0 was obtained for
families 37 and 26. This suggested strongly that the W-C EBS
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FIG. 2. Pedigrees of W-C EBS families 37 and 26 and the chromosomal segregation of four polymorphic loci. Numbers were assigned to
members for which blood was obtained (skin biopsies and blood were obtained from members 37.7 and 26.5). The individual's alleles for each
locus are boxed. Solid symbols, members clinically affected with W-C EBS; open symbols, unaffected individuals; cross bar to right, deceased;
cross bar to left, divorced; square, male; circle, female.
lesion in these families resided within the keratin locus on
chromosome 12q11-q13, specifically, within the K5 gene.
To verify that the heterozygous loss of the Fok I site from
families 37 and 26 was due to the T-* G transversion at codon
161, we sequenced their genomic DNAs (Fig. 5). Indeed, the
exact same T -- G transversion was present in both families
and cosegregated with the disease. Moreover, the T -* G
transversion was present in =50% ofthe functional K5 alleles
of affected, but not unaffected, family members.
Complete sequencing ofthe K5 cDNA from individual 37.7
did not uncover any additional mutations. However, there
were a few discrepancies between published K5 sequences
(16, 17) and our four wild-type K5 DNAs. The K5 residues
Ser-9 (TCC), Gly-10 (GGA), Ala-11 (GCG), Ser-79 (AGT),
Gly-80 (GGT), Ser-386 (TCT), and Ser-558 (AGC) were as
reported by Lersch et al. (17), not Eckert and Rorke (16).
Residues Arg-37 (CGG), Ser-38 (TCC), Glu-261 (GAA), and
I non-coding
G A T C_ I
Glu-271 (GAG) were as reported by Eckert and Rorke
(16), not Lersch et al. (17). In addition, there were two
polymorphisms, one in the head [Gly or Glu at position
138; (GGA)/(GAA)] and one in the rod [Glu or Asp at posi-
tion 197; (GAA)/(GAC)]. Polymorphisms in the variable
head and tail domains of other keratins have been described
(20, 21).
DISCUSSION
A number of lines of evidence indicates that the T -- G
transversion at nt 482 ofhuman K5 underlies the genetic basis
for W-C EBS in families 37 and 26: (i) The mutation was not
found in 156 wild-type alleles. (ii) The mutation was carried
only by affected family members. (iii) The mutation was
inherited in an autosomal dominant fashion, characteristic of
the pattern of inheritance in these families. (iv) The mutation
D. control (w.t.)
G A T C
W-C EBS 37.7
A. Total mRNA
coding- B. cloned (EBS) C. cloned (w.t.)
















FIG. 3. G T transversion at codon 161 in an affected W-C EBS individual. PCR was used to amplify K5 sequences from epidermal mRNA
of keratinocytes cultured from patient 37.7. Amplified fragments from two rounds of PCR were subjected to DNA sequencing, either directly
or after subcloning. Note the A -- C transversion (T -- G in the coding strand) at nt 482 (codon 161) in one of two 37.7 alleles (arrowhead).
Sequences are from the following samples: (A) Total K5 PCR mixture of 37.7 mRNA. (B) Cloned cDNA from the mRNA of mutant 37.7 allele.
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FIG. 4. Heterozygous obliteration of a Fok I site in affected two
family members of two W-C EBS families. Genomic DNAs were one
PCR-amplified to produce a 555-bp K5 DNA fragment encompassing of 1
the T - G transition at nt 482. DNAs were digested with FokI, which
cleaved wild-type DNA to 466 bp (and a small 89-bp fragment that is and
not shown). After digestion, DNAs were resolved by agarose gel and
electrophoresis and stained with ethidium bromide. (A) Lanes: L, a T
DNA ladder; C, control DNA; remaining lanes, family 37 DNAs from mut
affected members 10, 9, 5, 4, 2, 1, and 7 and unaffected members 8, gen
6, and 3. (B) (Left) Lanes: U, undigested PCR fragment; family 26 It
DNAs from affected members 5, 1, and 2 and unaffected member 4.
(Right) Representative examples of affected members from W-C pot
EBS families 12, 31, 18, 32, and 34. (C and D) Genomic DNAs from nas(
blood of first 57 of 78 normal individuals. tion
med
was in the K5 gene on chromosome 12 (18), and the peak lod othe
score at 6 = 0 was 3.0 for chromosome 12 (-7.2 for are
chromosome 17). cell
Residue 161 of K5 is near or at the junction between the ylat
head and rod domains of the IF polypeptide. This residue is resp
Ile in 87% of type II keratins (Fig. 6) and is in a region vim
essential for 10-nm filament assembly (25). The other W-C pho
EBS incidences did not contain the Ile-161 -* Ser mutation. ous
However, given (i) the degree of conservation of other IF in V
W -- - W-C EBS#37 I--
A. 37.7 B. 37.8 C. 37.9 D. 37.1 0 E. 26.1
(EBS) (U) (EBS) (EBS) (EBS)
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idues, (ii) the importance ofother residues in IF assembly,
(iii) the obligatory heteropolymeric nature of keratin IFs,
probable that point mutations in other critical residues of
er the K5 or K14 genes could generate the W-C EBS
notype. It is also possible that mutations within a minor
,al keratin or in an IF-associated protein might account for
ne W-C EBS cases.
t is interesting that the mildest cases of EBS (present
dy) and EH (24) have mutations in the type II keratin head,
acent to the rod, whereas the moderate case of EBS has
utation centrally in one of the a-helical domains of the
e I rod (5), and more severe cases of EBS (4, 6) and EH
23) have mutations within the highly conserved ends of
type I or type II rods. It is both relevant and revealing that
e of the 16 incidences of K-EBS or D-M EBS had the
161 -+ Ser W-C EBS K5 mutation, and none of the W-C
S patients had the Arg-125 -> Cys or His D-M EBS K14
tation. Thus, a trend seems to be emerging relating
ation of mutations within the keratin polypeptide to dis-
e severity.
Ve were surprised that the same residue was mutated in
of nine W-C EBS families. Although a high frequency of
other mutation, Arg -- Cys or His, has been found in 6
L1 incidences of EBS and EH (4, 22, 23), this site is also
ot spot for C -+ T transition mutagenesis by methylation
deamination (26). In contrast, the Ile -* Ser mutation is
' G transversion that is not a known hot spot for
tagenesis. It may be that this is one of only a few ways of
ierating the W-C EBS phenotype.
t is intriguing that the Ile -+ Ser mutation generates a
ential phosphorylation site, Ser-Gln-Arg, for protein ki-
e C (27). While the possible significance of this observa-
i remains to be determined, it is notable that cdc kinase-
diate phosphorylation of serines in the head regions oftwo
er IF proteins, lamin A (type V) and vimentin (type III),
responsible for destabilizing these IF networks in a
[-cycle-dependent fashion (28-31). Moreover, phosphor-
Lion of IFs by protein kinase C can trigger such diverse
ponses as diassembly of in vitro-formed polymers of
entin (32) and nuclear import oflamin B in vivo (33). Thus
sphorylation might play a role in mediating the deleteri-
,effects of the Ile -+ Ser mutation on IF network formation
V-C EBS basal cells.
- W-C EBS #26 --
F. 26.2 G. 26.4
(EBS) (U)






















FIG. 5. T -- G transversion in K5 codon 161 cosegregates with affected members of W-C EBS families 37 and 26. For genomic DNA from
each available member of families 37 and 26, the region encompassing the putative T482 -, G transition was amplified by PCR, and the fragment
was sequenced. Representative examples of coding strand sequences from affected (EBS) and unaffected (U) individuals are shown.
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